McKinley Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,590
| Closed | -$9.06M | – | 157 |
|
|
2024
Q1 | $9.06M | Hold |
15,590
| – | – | 1.09% | 23 |
|
|
2023
Q4 | $8.28M | Hold |
15,590
| – | – | 1.06% | 23 |
|
|
2023
Q3 | $7.89M | Sell |
15,590
-5,280
| -25% | -$2.81M | 1.11% | 21 |
|
|
2023
Q2 | $10.9M | Sell |
20,870
-2,700
| -11% | -$1.46M | 1.45% | 10 |
|
|
2023
Q1 | $13.6M | Hold |
23,570
| – | – | 1.8% | 9 |
|
|
2022
Q4 | $13M | Hold |
23,570
| – | – | 1.74% | 8 |
|
|
2022
Q3 | $12M | Hold |
23,570
| – | – | 1.62% | 10 |
|
|
2022
Q2 | $12.8M | Buy |
23,570
+5,540
| +31% | +$3.05M | 1.67% | 10 |
|
|
2022
Q1 | $10.6M | Buy |
18,030
+2,460
| +16% | +$1.41M | 1.06% | 23 |
|
|
2021
Q4 | $10.4M | Buy |
15,570
+4,370
| +39% | +$2.73M | 0.93% | 27 |
|
|
2021
Q3 | $6.4M | Buy |
11,200
+8,930
| +393% | +$4.9M | 0.6% | 53 |
|
|
2021
Q2 | $1.15M | Hold |
2,270
| – | – | 0.08% | 144 |
|
|
2021
Q1 | $1.04M | Hold |
2,270
| – | – | 0.08% | 146 |
|
|
2020
Q4 | $1.06M | Hold |
2,270
| – | – | 0.08% | 143 |
|
|
2020
Q3 | $1M | Hold |
2,270
| – | – | 0.08% | 141 |
|
|
2020
Q2 | $823K | Hold |
2,270
| – | – | 0.06% | 145 |
|
|
2020
Q1 | $644K | Hold |
2,270
| – | – | 0.05% | 151 |
|
|
2019
Q4 | $737K | Buy |
+2,270
| New | +$688K | 0.05% | 162 |
|
|
2019
Q3 | – | Sell |
-2,270
| Closed | -$667K | – | 210 |
|
|
2019
Q2 | $667K | Buy |
+2,270
| New | +$625K | 0.04% | 175 |
|
|
2018
Q2 | – | Sell |
-2,587
| Closed | -$534K | – | 339 |
|
|
2018
Q1 | $534K | Buy |
2,587
+960
| +59% | +$202K | 0.03% | 161 |
|
|
2017
Q4 | $309K | Hold |
1,627
| – | – | 0.02% | 266 |
|
|
2017
Q3 | $308K | Sell |
1,627
-120
| -7% | -$21.7K | 0.01% | 285 |
|
|
2017
Q2 | $305K | Hold |
1,747
| – | – | 0.01% | 281 |
|
|
2017
Q1 | $268K | Hold |
1,747
| – | – | 0.01% | 324 |
|
|
2016
Q4 | $246K | Sell |
1,747
-150
| -8% | -$22.1K | 0.01% | 345 |
|
|
2016
Q3 | $302K | Sell |
1,897
-80
| -4% | -$12.3K | 0.01% | 313 |
|
|
2016
Q2 | $292K | Hold |
1,977
| – | – | 0.01% | 297 |
|
|
2016
Q1 | $280K | Sell |
1,977
-2,190
| -53% | -$293K | 0.01% | 280 |
|
|
2015
Q4 | $591K | Sell |
4,167
-432
| -9% | -$57.6K | 0.03% | 242 |
|
|
2015
Q3 | $562K | Sell |
4,599
-580
| -11% | -$75.6K | 0.03% | 237 |
|
|
2015
Q2 | $672K | Sell |
5,179
-280
| -5% | -$36.5K | 0.03% | 242 |
|
|
2015
Q1 | $733K | Hold |
5,459
| – | – | 0.03% | 232 |
|
|
2014
Q4 | $684K | Buy |
5,459
+2,320
| +74% | +$282K | 0.03% | 233 |
|
|
2014
Q3 | $382K | Sell |
3,139
-380
| -11% | -$46.2K | 0.02% | 269 |
|
|
2014
Q2 | $415K | Hold |
3,519
| – | – | 0.02% | 252 |
|
|
2014
Q1 | $423K | Sell |
3,519
-2,089
| -37% | -$248K | 0.02% | 303 |
|
|
2013
Q4 | $624K | Buy |
5,608
+1,359
| +32% | +$135K | 0.02% | 281 |
|
|
2013
Q3 | $392K | Hold |
4,249
| – | – | 0.02% | 304 |
|
|
2013
Q2 | $360K | Buy |
+4,249
| New | +$354K | 0.02% | 283 |
|
Other funds holding TMO
McKinley Capital Management's TMO Position: Q2 2024 in Review
McKinley Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 15,590 shares — an estimated $9.06M sold.
McKinley Capital Management first reported a position in TMO in Q2 2013 and held it in 39 quarters. The position peaked at $13.6M in Q1 2023. 2,543 funds tracked by Wall St. Rank hold TMO as of Q2 2024.
- McKinley Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
- McKinley Capital Management sold 15,590 Thermo Fisher Scientific shares in Q2 2024, an estimated $9.06M.
- McKinley Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 39 quarters.
- McKinley Capital Management's Thermo Fisher Scientific position peaked at $13.6M in Q1 2023.
- 2,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.
Based on McKinley Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.